Sharon L Christ, D Diane Zheng, Bonnielin K Swenor, Byron L Lam, Sheila K West, Stacey L Tannenbaum, Beatriz E Muñoz, David J Lee. JAMA Ophthalmol 2014
Times Cited: 62
Times Cited: 62
S Sharma, A Oliver-Fernandez, J Bakal, H Hollands, G C Brown, M M Brown. Br J Ophthalmol 2003
Times Cited: 56
Times Cited: 56
List of shared articles
Times cited
Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease.
Scott Johnson, Marric Buessing, Thomas O'Connell, Sarah Pitluck, Thomas A Ciulla. JAMA Ophthalmol 2019
Scott Johnson, Marric Buessing, Thomas O'Connell, Sarah Pitluck, Thomas A Ciulla. JAMA Ophthalmol 2019
Quality of life associated with no light perception vision.
Gary C Brown, Melissa M Brown, Joshua D Stein, Sanjay Sharma. Can J Ophthalmol 2022
Gary C Brown, Melissa M Brown, Joshua D Stein, Sanjay Sharma. Can J Ophthalmol 2022
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration.
Gary C Brown, Melissa M Brown, Sara Rapuano, David Boyer. Am J Ophthalmol 2020
Gary C Brown, Melissa M Brown, Sara Rapuano, David Boyer. Am J Ophthalmol 2020
Health care stakeholder perceptions of vision loss.
Gary C Brown, Melissa M Brown. Surv Ophthalmol 2019
Gary C Brown, Melissa M Brown. Surv Ophthalmol 2019